In 2025, more than 38 million, or 1 in 10 Americans, live with Type 2 diabetes. In the rapidly evolving landscape of the modern health care system, traditional care strategies for Type 2 diabetes often vastly overlook long-term individual and societal …
Canadians have rallied together like never before to support each other and stand up for Canada in the face of U.S. tariffs and annexation threats. People living with diabetes need that same spirit of solidarity around them to defeat a persistent stigm…
Chronic, non-communicable diseases are the leading cause of death worldwide and make up 8 of the 10 top causes of death in the U.S. Across several chronic diseases, the U.S. has a higher burden of illness than peer nations. The reasons why are complex …
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Board-certified pediatric endocrinologist, field medical director for type 1 diabetes immunology (T1D) at Sanofi, and T1D survivor Shara Bialo discusses the article, ̶…
Nearly 3 million Americans live sicker, shorter lives in the hundreds of rural counties where doctor shortages are the worst and poor internet connections mean little or no access to telehealth services.
As a board-certified pediatric endocrinologist, the field medical director for type 1 diabetes immunology (T1D) at Sanofi, and someone who was diagnosed with T1D as a child, it’s fair to say that much of my life has revolved around the disease. I…
As a board-certified pediatric endocrinologist, the field medical director for type 1 diabetes immunology (T1D) at Sanofi, and someone who was diagnosed with T1D as a child, it’s fair to say that much of my life has revolved around the disease. I…
With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick. But some parents say it falls to them to keep an eye on blood sugar levels from home or work — even though they may not be able to quickly reach their child when something’s wrong.
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us as we sit down with Gary Marc Rothenberg, a podiatrist, to explore the unique connections between Olympic-level perseverance and the day-to-day challenges of chron…
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
